Perfil
David Hyman has worked as a Chief Medical Officer at Eli Lilly & Co. since 2023 and at Loxo Oncology, Inc. since 2020.
Cargos activos de David Hyman
| Empresas | Cargo | Inicio |
|---|---|---|
| LOXO ONCOLOGY INC | Chief Tech/Sci/R&D Officer | 01/01/2020 |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | 16/10/2023 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Empresas privadas | 1 |
|---|---|
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
- Bolsa de valores
- Insiders
- David Hyman
